CLINDAMYCIN HYDROCHLORIDE
- Product NDC
- 50268-185
- 11-digit product format
- 502680185
- Labeler code
- 50268
- Product ID
- 50268-185_0e860109-7258-1c28-e063-6394a90a50ef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA207402
- Marketing category
- ANDA
- Marketing start
- 2020-10-27
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| T20OQ1YN1W | CLINDAMYCIN HYDROCHLORIDE | 21462-39-5 | CLINDAMYCIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50268-185-15 | 50268018515 | 50 BLISTER PACK in 1 BOX (50268-185-15) / 1 CAPSULE in 1 BLISTER PACK (50268-185-11) | 50 blister pack | 2020-10-27 | No | No | Historical |